Cargando…
Cardiogenic and Myogenic Gene Expression in Mesenchymal Stem Cells After 5-Azacytidine Treatment
Objective: 5-Azacytidine is a hypomethylating agent that is used for the treatment of myelodysplastic syndrome. This histone modifier is widely employed and plays a nonspecific role in influencing the differentiation capability of stem cells. The ability of bone marrow mesenchymal stem cells to diff...
Autores principales: | Supokawej, Aungkura, Kheolamai, Pakpoom, Nartprayut, Kuneerat, U-pratya, Yaowalak, Manochantr, Sirikul, Chayosumrit, Methichit, Issaragrisil, Surapol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878477/ https://www.ncbi.nlm.nih.gov/pubmed/24385773 http://dx.doi.org/10.4274/Tjh.2012.0161 |
Ejemplares similares
-
Endothelial Progenitor Cell Migration-Enhancing Factors in the Secretome of Placental-Derived Mesenchymal Stem Cells
por: Kamprom, Witchayaporn, et al.
Publicado: (2016) -
Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control
por: Churdchomjan, Worachat, et al.
Publicado: (2010) -
Dual Small-Molecule Targeting of SMAD Signaling Stimulates Human Induced Pluripotent Stem Cells toward Neural Lineages
por: Wattanapanitch, Methichit, et al.
Publicado: (2014) -
One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system
por: Wattanapanitch, Methichit, et al.
Publicado: (2018) -
Osteoporosis: the current status of mesenchymal stem cell-based therapy
por: Phetfong, Jitrada, et al.
Publicado: (2016)